Clinical trial Recruiting at 1 site Observational Ages 18 to 70

Nociplastic Pain in SAPS: A Look at Pain Types in Shoulder Pain

Official title: Prevalence of Nociplastic Pain Phenotype in Patients Diagnosed With Subacromial Pain Syndrome (SAPS) - a Cross-sectional Study

Run by Vejle Hospital · NCT07792434 · Data updated 2026-11-12

This study tests how common nociplastic pain is among people with subacromial pain syndrome who have shoulder pain for at least 3 months.

More Shoulder Pain trials

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexAll
Enrollment400 (estimated)
SponsorVejle Hospital
Academic / other
Locations1 site (Vejle)
StatusRecruiting
StartedOctober 19, 2026
Main results expectedAugust 2028
Study endsAugust 2028
Registry record updatedOctober 23, 2026
Trial IDNCT07792434 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–70 with SAPS for 3+ months, pain during active elevation, and at least 3/5 positive shoulder tests.

Probably not a fit

Patients with non-SAPS shoulder conditions or those failing to meet the inclusion criteria may not benefit from these findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cross-sectional study aims to estimate the proportion of SAPS patients who meet the IASP criteria for nociplastic pain during a clinical evaluation. Participants are adults aged 18–70 with SAPS, at least 3 months of shoulder pain, and positive results on at least three shoulder tests. The primary outcome is the share of patients classified as nociplastic, helping to understand pain mechanisms behind SAPS. The study highlights the potential mismatch between traditional treatments and underlying pain phenotypes and may guide more personalized care.

Why it matters

Potential benefit: If nociplastic pain is common in SAPS, clinicians may tailor treatments to pain mechanisms beyond conventional exercises.

How similar studies have gone: Previous work suggests facet pain phenotyping is feasible in musculoskeletal conditions, but applying IASP nociplastic criteria to SAPS is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosed with SAPS (dm751, dm753, dm754, dm755
2. Shoulder pain ≥ 3 months
3. ≥ 3 out of 5 specific shoulder tests
4. Age 18-70 years
5. Increased pain during active arm elevation
6. Pain during active elevation ≥ 3 (VAS)

Exclusion Criteria:

1. Severe visual impairment
2. Epilepsy
3. Severe cognitive or physical impairment
4. Language barrier (Danish)

Where it's running

  • Vejle Hospital
    Vejle, Denmark
    Recruiting

Study contacts

  • Principal investigator: Thomas Sørensen, PT, Cand.san — University of Southern Denmark
  • Study coordinator: Thomas Sørensen, PT, Cand.san
  • Email: thomas.soerensen1@rsyd.dk
  • Phone: +4579409871

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.